The Obesity Drug Pipeline Analysis provides insights into the rapidly expanding field of anti-obesity therapeutics, driven by the global rise in obesity prevalence. It highlights promising investigational drugs, including GLP-1 receptor agonists, dual agonists, and other metabolic modulators currently in various stages of clinical development. With obesity linked to numerous comorbidi... https://www.expertmarketresearch.com/clinical-trials/obesity-drug-pipeline-insight